Skip to content
10-Q

Quarterly Report

PHARMOS CORP

0001513160-12-000027

← back to feed
Filed
Apr 16, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · Apr 16, 2012 60.02M sh
Operating Cash Flow Q1 2012 · Mar 31, 2012 −$518.65K
Operating Cash Flow Q1 2012 · Mar 31, 2011 −$361.83K
Cash And Equivalents Q1 2012 · Mar 31, 2012 $1.02M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $1.54M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $2.78M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $3.14M
Stockholders Equity Q1 2012 · Mar 31, 2012 −$188.8K
Stockholders Equity Q1 2012 · Dec 31, 2011 $301.15K
Current Liabilities Q1 2012 · Mar 31, 2012 $1.34M
Current Liabilities Q1 2012 · Dec 31, 2011 $1.36M
Total Liabilities Q1 2012 · Mar 31, 2012 $1.34M
Total Liabilities Q1 2012 · Dec 31, 2011 $1.36M
Current Assets Q1 2012 · Mar 31, 2012 $1.15M
Current Assets Q1 2012 · Dec 31, 2011 $1.66M
Total Assets Q1 2012 · Mar 31, 2012 $1.15M
Total Assets Q1 2012 · Dec 31, 2011 $1.66M
Sga Expense Q1 2012 · Mar 31, 2012 $260.06K
Sga Expense Q1 2012 · Mar 31, 2011 $294.35K
Rd Expense Q1 2012 · Mar 31, 2012 $290.66K
Rd Expense Q1 2012 · Mar 31, 2011 $281.78K
Net Income Q1 2012 · Mar 31, 2012 −$576.31K
Net Income Q1 2012 · Mar 31, 2011 −$603.13K
Operating Income Q1 2012 · Mar 31, 2012 −$551.34K
Operating Income Q1 2012 · Mar 31, 2011 −$576.75K